Navigation Links
Corgenix to Exhibit AspirinWorks(R) Test at ACC.09
Date:3/18/2009

Test measures urinary 11dhTxB2 to assess aspirin effect

DENVER, March 18 /PRNewswire/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, has announced it will be exhibiting its AspirinWorks(R) Test March 29 - 31 at the American College of Cardiology (ACC) 58th Annual Scientific Session. The annual meeting will take place in Orlando, Fla., at the Orange County Convention Center.

Corgenix representatives will be on-hand during ACC.09 at booth No. 1162 to answer questions about the AspirinWorks Test, including availability of the test, the latest supporting clinical data and ordering information. Complimentary AspirinWorks Tests will be offered to qualified attendees during regular exhibit hours March 29-31. Test results will be provided after the conference.

The AspirinWorks Test is the only FDA-cleared test that measures urinary 11dhTxB2 to accurately determine the effect of aspirin in apparently healthy individuals. 11dhTxB2 is a metabolite of thromboxane A2, the target of aspirin therapy.

"The phenomenon of aspirin effect has been validated in numerous randomized, controlled prospective outcome trials and demonstrates the value of understanding a patient's individual response to aspirin," said Gordon Ens, clinical director of Corgenix Medical Corporation. "The issue of 'aspirin resistance' is real, clinically important and deserves further examination. The ACC.09 conference presents an ideal environment in which to discuss the efficacy of this test."

The AspirinWorks Test was launched in the U.S. in June 2007 following FDA 510(k) clearance, and it is now available nationwide through major medical laboratories, including Quest, LabCorp and SpectraCell, as well as direct to consumers through HealthCheckUSA (www.HealthCheckUSA.com). The test targets
'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corgenix Signs Technology Licensing Agreement With Japanese Government
2. Corgenix to Exhibit AspirinWorks(R) Test at ACC 2008 Meeting in Chicago
3. Corgenix Announces FDA Clearance for IgG Anti-AtherOx(R) Test Kit
4. Corgenix to Host Conference Call to Discuss Third Quarter Fiscal 2008 Results
5. Corgenix to Exhibit AspirinWorks(R) Test at ADA 2008 Meeting in San Francisco
6. Corgenix Expands Scientific Advisory Board
7. Corgenix to Host Conference Call to Discuss Fiscal 2008 Results
8. Corgenix Reports Fiscal 2008 Financial Results
9. Corgenix Receives Third U.S. Patent on AtherOx(R) Technology
10. Corgenix to Exhibit AspirinWorks(R) Test, Discuss New CHARISMA Trial Results at AHA 2008 Meeting
11. Corgenix to Host Conference Call to Discuss First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... 2014 Advancing the front lines ... chemical and biological threats is the mission of ... Institute (WPI) and the Georgian National Academy of ... Peace and Security Programme of the North Atlantic ... Research Workshop series, the event is titled “Nanotechnology ...
(Date:9/12/2014)... On Thursday, September 11, 2014, the NASDAQ Composite ended ... the day 0.12% lower at 17,049.00, and the S&P 500 ... as seven out of ten sectors ended the session in ... day at 741.83, down 0.33%, while the index has advanced ... on the following equities: Exelixis Inc. (NASDAQ: EXEL ...
(Date:9/11/2014)... researchers have gained new insight into what may ... neuronal signaling associated with this disease. They did ... of healthy individuals and of patients with schizophrenia ... to release neurotransmitters, such as dopamine, that are ... various disorders. By discovering a simple method for ...
(Date:9/11/2014)... surface of graphene, a one atom thick sheet of ... graphene oxide; a form of graphene that could have ... industries. Applied as paint, it could provide an ultra-strong, ... , Graphene oxide solutions can be used to ... even conventional bricks. After a simple chemical treatment, the ...
Breaking Biology Technology:Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 2Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 3Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 4Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics 5Stem cells help researchers understand how schizophrenic brains function 2Graphene paints a corrosion-free future 2
... Israel, June 17 BSP Ltd.,( http://www.bsp.co.il/pressall.asp ) ... non-invasive diagnosis and monitoring of Ischemic Heart,Disease, announced ... private,funding round, that included existing shareholders in the ... the HyperQ(TM), a cutting-edge technology that offers,highly reliable, ...
... a trend of unprecedented,growth in biotechnology innovation, targeted ... in the past year in,terms of development and ... at the 2008 BIO International Convention in San ... the need to measure,innovation in the market, in ...
... 17 /PRNewswire-FirstCall/ - Oncothyreon Inc.,(Nasdaq: ONTY ) ... in,a Phase 1 trial of PX-866 in patients ... compound designed to inhibit the activity of,phosphatidylinositol-3-kinase (PI-3K), ... a potent inhibitor of PI-3K, a component of ...
Cached Biology Technology:BSP Raises $2.6 Million Dollars From Private Investors 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 3In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 4In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 5Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 2Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 3Oncothyreon initiates Phase 1 trial of PX-866 cancer compound 4
(Date:9/12/2014)... happened on the way to dealing with climate ... dollars, worth of previously unreachable oil and natural ... and benefits from "fracking," which requires ... deep into underground rock formations, are the subject ... and government databases. The survey covers not only ...
(Date:9/11/2014)... autism often show a reduced frequency of social ... repetitive solitary behaviors. Autism has also been linked ... involved in processing emotions. Now Caltech researchers have ... that control whether the animal engages in social ... have implications for understanding neural circuit dysfunctions that ...
(Date:9/11/2014)... associate professor of mechanical engineering at Worcester ... the university,s Integrative Materials Design Center (iMdc), ... the National Science Foundation (NSF) to support ... manufacture metal-ceramic composites, which can be used ... efficient, while significantly increasing their performance. , ...
Breaking Biology News(10 mins):Stanford-led study assesses the environmental costs and benefits of fracking 2Stanford-led study assesses the environmental costs and benefits of fracking 3Stanford-led study assesses the environmental costs and benefits of fracking 4Tipping the balance of behavior 2Tipping the balance of behavior 3NSF funds new method for making materials that can make lighter, more efficient vehicles 2NSF funds new method for making materials that can make lighter, more efficient vehicles 3
... lab tests of "killer paper," a material intended for ... preserve foods by fighting the bacteria that cause spoilage. ... contains a coating of silver nanoparticles, which are powerful ... that silver already finds wide use as a bacteria ...
... contain atomic clues as to the habitats in which ... has important implications for predicting the effects of climate ... the animal kingdom. Applying a method previously only ... on plants, scientists from the University of Cambridge can ...
... MOUNTAIN VIEW, Calif., Jan. 10, 2011 Based ... monitoring market, Frost & Sullivan recognizes Cardiocom with ... for Enabling Technology. Cardiocom provides integrated clinical telehealth ... healthcare community. (Logo:   http://photos.prnewswire.com/prnh/20081117/FSLOGO ) ...
Cached Biology News:Insects hold atomic clues about the type of habitats in which they live 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 2Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 3Frost & Sullivan Recognizes Cardiocom as a Technology Enabler for Superior Cost-Effective Remote Chronic Care Management 4
Fingerprinting II dimensioning techniques is an optional module that adds principal component analysis, multidimensional scaling, discriminant analysis and MANOVA, and self-organizing maps to the Fin...
Fingerprinting II Informatix optional matrix types module, is an optional module that adds external similarity and distance matrix functions to the Fingerprinting II Informatix software package....
... Dyad instrument is the most advanced thermal ... world-class thermal performance, the Dyad also boasts ... as point-and-click navigation via touch pad or ... easily and economically expanded to a four-bay ...
...
Biology Products: